Article Versions Notes

Galar A, Valerio M, Catalán P, García-González X, Burillo A, Fernández-Cruz A, Zataráin E, Sousa-Casasnovas I, Anaya F, Rodríguez-Ferrero ML, et al. Valganciclovir—Ganciclovir Use and Systematic Therapeutic Drug Monitoring. An Invitation to Antiviral Stewardship. Antibiotics. 2021; 10(1):77. https://doi.org/10.3390/antibiotics10010077

Galar, Alicia, Maricela Valerio, Pilar Catalán, Xandra García-González, Almudena Burillo, Ana Fernández-Cruz, Eduardo Zataráin, Iago Sousa-Casasnovas, Fernando Anaya, María Luisa Rodríguez-Ferrero, and et al. 2021. "Valganciclovir—Ganciclovir Use and Systematic Therapeutic Drug Monitoring. An Invitation to Antiviral Stewardship" Antibiotics 10, no. 1: 77. https://doi.org/10.3390/antibiotics10010077

Galar, A., Valerio, M., Catalán, P., García-González, X., Burillo, A., Fernández-Cruz, A., Zataráin, E., Sousa-Casasnovas, I., Anaya, F., Rodríguez-Ferrero, M. L., Muñoz, P., & Bouza, E. (2021). Valganciclovir—Ganciclovir Use and Systematic Therapeutic Drug Monitoring. An Invitation to Antiviral Stewardship. Antibiotics, 10(1), 77. https://doi.org/10.3390/antibiotics10010077